跳至主要内容
临床试验/NCT03628625
NCT03628625Unknown2 期

Letrozole Pretreatment With Misoprostol for Induction of Abortion In First-Trimester Missed Miscarriage: A Randomized Controlled Trial

Ain Shams Maternity Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年9月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
80
试验地点
1
主要终点
Incidence of complete miscarriage

研究概览

简要总结

This study compares the success rate of letrozole and misoprostol versus misoprostol alone for medical termination of first trimester pregnancy.

详细描述

According to the American college of obstetricians and gynecologists (2005), medical abortion is an acceptable alternative for surgical procedures in pregnant women with gestational age of less than 49 days based on the last menstrual period

Oral or vaginal misoprostol causes complete abortion in almost 85% of cases within seven days before the 12th week

letrozole administration with misoprostol raises the rate of complete abortion

Hypothesis

In women with missed miscarriage in the first trimester undergoing induction of abortion pre-treatment with letrozole before misoprostol may lead to abortion rate similar to misoprostol alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Gestational age less than 64 days gestation (<9 wks).
  • Hemoglobin >10 g/dL.
  • BMI between 18.5 kg/m2 and 25 kg/m
  • Missed abortion.

排除标准

  • Molar pregnancy.
  • Fibroid uterus.
  • Uterine anomalies.
  • Coagulopathy.
  • Medical disorder that contraindicate induction of abortion (e.g. heart failure).
  • Previous attempts for induction of abortion in the current pregnancy.
  • Allergy to misoprostol or letrozole.

研究组 & 干预措施

Study group

Experimental

3 tablets of Letrozole 2.5 mg will be given as single daily dose, 7.5 mg per day for two days at home and the third dose will be given on admission to hospital on day 3 and will be followed by vaginal misoprostol 800 mcg every three hours up to maximum two doses.

干预措施: Letrozole 2.5mg (Drug)

Study group

Experimental

3 tablets of Letrozole 2.5 mg will be given as single daily dose, 7.5 mg per day for two days at home and the third dose will be given on admission to hospital on day 3 and will be followed by vaginal misoprostol 800 mcg every three hours up to maximum two doses.

干预措施: Misoprostol (Drug)

Control group

Placebo Comparator

three tablets of placebo will be given as a single daily dose, for two days at home and will be admitted on day 3 and continue treatment with misoprostol 800 mcg every three hours up to maximum two doses

干预措施: Placebo (Drug)

Control group

Placebo Comparator

three tablets of placebo will be given as a single daily dose, for two days at home and will be admitted on day 3 and continue treatment with misoprostol 800 mcg every three hours up to maximum two doses

干预措施: Misoprostol (Drug)

结局指标

主要结局

Incidence of complete miscarriage

时间窗: 6 hours

次要结局

  • Need for surgical evacuation of the products of conception(6 hours)
  • Incidence of Septic Abortion(1 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr- dina yahia mansour

Lecturer of Obstetrics and Gynecology Ain Shams University

Ain Shams Maternity Hospital

研究点 (1)

Loading locations...

相似试验